検索
BioLine RX Ltd
BLRXウォッチリストに追加
3.285USD
0.0000.00%
終値 07/02, 13:00（ET）15分遅れの株価
14.29M時価総額
損失額直近12ヶ月PER
詳細情報 BioLine RX Ltd 企業名
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
BioLine RX Ltdの企業情報
企業コードBLRX
会社名BioLine RX Ltd
上場日Jan 30, 2007
最高経営責任者「CEO」Serlin (Philip Adam)
従業員数28
証券種類Depository Receipt
決算期末Jan 30
本社所在地Modi'in Technology Park
都市MODIIN
証券取引所NASDAQ OMX - NASDAQ BASIC
国Israel
郵便番号7177871
電話番号97286429100
ウェブサイトhttps://www.biolinerx.com/
企業コードBLRX
上場日Jan 30, 2007
最高経営責任者「CEO」Serlin (Philip Adam)
BioLine RX Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Raphael (Rafi) Hofstein, Ph.D.
Dr. Raphael (Rafi) Hofstein, Ph.D.
Director
Director
--
--
Ms. Nurit Benjamini
Ms. Nurit Benjamini
External Director
External Director
--
--
Dr. Avraham (Avi) Molcho
Dr. Avraham (Avi) Molcho
External Director
External Director
--
--
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Director
Director
--
--
Mr. Philip Adam (Phil) Serlin
Mr. Philip Adam (Phil) Serlin
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Sandra Panem, Ph.D.
Dr. Sandra Panem, Ph.D.
Director
Director
--
--
Ms. Mali Zeevi
Ms. Mali Zeevi
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Hillit Mannor Shachar
Dr. Hillit Mannor Shachar
Vice President - Business Development
Vice President - Business Development
--
--
Dr. Ella Sorani
Dr. Ella Sorani
Vice President - Development
Vice President - Development
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Raphael (Rafi) Hofstein, Ph.D.
Dr. Raphael (Rafi) Hofstein, Ph.D.
Director
Director
--
--
Ms. Nurit Benjamini
Ms. Nurit Benjamini
External Director
External Director
--
--
Dr. Avraham (Avi) Molcho
Dr. Avraham (Avi) Molcho
External Director
External Director
--
--
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Director
Director
--
--
Mr. Philip Adam (Phil) Serlin
Mr. Philip Adam (Phil) Serlin
Chief Executive Officer
Chief Executive Officer
--
--
よくある質問
BioLine RX Ltdの上位5名の株主は誰ですか？
BioLine RX Ltdの上位5名の株主は以下のとおりです。Dr. Aharon Schwartz, Ph.D.
BioLine RX Ltd（BLRX）の株式を保有している機関の数はいくつですか？
2026Q1時点で、BioLine RX Ltdの株式を保有している機関は60社あり、保有株式の総市場価値は約46.33Kで、全体の1.06%を占めています。2025Q4と比較して、機関の持ち株は-104547.00増加しています。